Frontiers Case report: Short-term eculizumab use in atypical HUS
Por um escritor misterioso
Descrição
Frontiers Case report: Eculizumab plus obinutuzumab induction in a deceased donor kidney transplant recipient with DEAP-HUS
Preemptive plasma therapy prevents atypical hemolytic uremic syndrome relapse in kidney transplant recipients - ScienceDirect
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
Frontiers Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report
Eculizumab for Atypical Hemolytic–Uremic Syndrome
Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era
Frontiers Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome
PDF] Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
PDF] Pathogenesis of Atypical Hemolytic Uremic Syndrome
PDF) Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome
PDF) Anti-factor H antibody and its role in atypical hemolytic uremic syndrome
Frontiers Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient
de
por adulto (o preço varia de acordo com o tamanho do grupo)
